Dallas, TX: ReportsandReports announce it will carry Belgium Orthopedic Devices Market Outlook to 2016 Market Research Report in its Store.

GlobalData’s medical equipment report, “Belgium Orthopedic Devices Market Outlook to 2016” provides key market data on the Belgium orthopedic devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories – Orthobiologics, Joint Reconstruction, Spinal Surgery, Trauma Fixation, Arthroscopy, Orthopedic Accessories, and Orthopedic Braces and Supports. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Browse all Medical Devices Market Research Reports

Browse all GlobalData Market Research Reports

Browse all Newly Published Market Research Reports

Reports and Reports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.

Ms. Sunita

7557 Rambler road,

Suite 727, Dallas, TX 75231

Tel: +1-888-989-8004

Website: http://www.reportsandreports.com/

Blog: http://reportsnreports.wordpress.com/

Blog: http://reportsandreports.blogspot.com/

Dallas, TX: ReportsandReports announce it will carry Belgium In Vitro Diagnostics Market Outlook to 2016 Market Research Report in its Store.

GlobalData’s new report, “Belgium In Vitro Diagnostics Market Outlook to 2016” provides key market data on the Belgium In Vitro Diagnostics (IVD) market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories – clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture, and haematology. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

1.1 List of Tables

1.2 List of Figures

2.1 What is This Report About?

3.1 In Vitro Diagnostics, Market Segmentation

3.2 In Vitro Diagnostics, Belgium, Overall Revenue ($m), 2002-2016

3.3 In Vitro Diagnostics Market, Belgium, Revenue Mix ($m), 2009

3.4 In Vitro Diagnostics Market, Belgium, Category Contribution (%), 2009

3.5 In Vitro Diagnostics, Belgium, Company Share (2008-2009)

4.1 Clinical Chemistry, Market Segmentation

4.2 Clinical Chemistry Market, Belgium, Revenue Mix ($m), 2009

4.3 Clinical Chemistry Market, Belgium, Category Contribution (%), 2009

4.4 Clinical Chemistry Overall Revenue (2002-2016)

4.4.1 Clinical Chemisty Analyzers Revenue (2002-2016)

4.4.2 Urine Analysis Revenue (2002-2016)

4.5 Clinical Chemistry Distribution Share (2008-2009)

4.6 Clinical Chemistry, Belgium, Company Share (2008-2009)

5.1 Genetic Testing, Market Segmentation

5.2 Genetic Testing Market, Belgium, Revenue Mix ($m), 2009

5.3 Genetic Testing Market, Belgium, Category Contribution (%), 2009

5.4 Genetic Testing Overall Revenue (2002-2016)

5.5 Genetic Testing Distribution Share (2008-2009)

5.6 Genetic Testing, Belgium, Company Share (2008-2009)

6.1 Haematology, Market Segmentation

6.2 Haematology Market, Belgium, Revenue Mix ($m), 2009

6.3 Haematology Market, Belgium, Category Contribution (%), 2009

6.4 Haematology Overall Revenue (2002-2016)

6.4.1 Haematology Reagents Revenue (2002-2016)

6.4.2 Immunohaematology Revenue (2002-2016)

6.4.3 Haemostasis Revenue (2002-2016)

6.4.4 Haematology Rapid Tests Revenue (2002-2016)

6.4.5 Haematology Cell Counters Revenue (2002-2016)

6.5 Haematology Distribution Share (2008-2009)

6.6 Haematology, Belgium, Company Share (2008-2009)

7.1 Histology and Cytology, Market Segmentation

7.2 Histology And Cytology Market, Belgium, Revenue Mix ($m), 2009

7.3 Histology and Cytology Market, Belgium, Category Contribution (%), 2009

7.4 Histology And Cytology Overall Revenue (2002-2016)

7.4.1 Histology Revenue (2002-2016)

7.5 Histology And Cytology Distribution Share (2008-2009)

7.6 Histology And Cytology, Belgium, Company Share (2008-2009)

8.1 Immuno Chemistry, Market Segmentation

8.2 Immuno Chemistry Market, Belgium, Revenue Mix ($m), 2009

8.3 Immuno Chemistry Market, Belgium, Category Contribution (%), 2009

8.4 Immuno Chemistry Overall Revenue (2002-2016)

8.4.1 Disease Specific Immunochemistry Revenue (2002-2016)

8.4.2 Drug Related Testing Revenue (2002-2016)

8.4.3 Endocrinology Tests Revenue (2002-2016)

8.4.4 Immunochemistry Analyzers Revenue (2002-2016)

8.5 Immuno Chemistry Distribution Share (2008-2009)

8.6 Immuno Chemistry, Belgium, Company Share (2008-2009)

9.1 Infectious Immunology, Market Segmentation

9.2 Infectious Immunology Market, Belgium, Revenue Mix ($m), 2009

9.3 Infectious Immunology Market, Belgium, Category Contribution (%), 2009

9.4 Infectious Immunology Overall Revenue (2002-2016)

9.5 Infectious Immunology Distribution Share (2008-2009)

9.6 Infectious Immunology, Belgium, Company Share (2008-2009)

10.1 Microbiology Culture, Market Segmentation

10.2 Microbiology Culture Market, Belgium, Revenue Mix ($m), 2009

10.3 Microbiology Culture Market, Belgium, Category Contribution (%), 2009

10.4 Microbiology Culture Overall Revenue (2002-2016)

10.4.1 Microbiology Analyzers Revenue (2002-2016)

10.5 Microbiology Culture Distribution Share (2008-2009)

10.6 Microbiology Culture, Belgium, Company Share (2008-2009)

11.1 F. Hoffmann-La Roche Ltd.

11.1.1 Company Overview

11.1.2 Share in the Belgium In Vitro Diagnostics Market

11.2 Siemens Healthcare

11.2.1 Company Overview

11.2.2 Share in the Belgium In Vitro Diagnostics Market

11.3 Abbott Laboratories

11.3.1 Company Overview

11.3.2 Share in the Belgium In Vitro Diagnostics Market

11.4 bioMerieux S.A.

11.4.1 Company Overview

11.4.2 Share in the Belgium In Vitro Diagnostics Market

11.5 Bio-Rad Laboratories, Inc.

11.5.1 Company Overview

11.5.2 Share in the Belgium In Vitro Diagnostics Market

11.6 Beckman Coulter, Inc.

11.6.1 Company Overview

11.6.2 Share in the Belgium In Vitro Diagnostics Market

11.7 Inverness Medical Innovations, Inc.

11.7.1 Company Overview

11.8 Becton, Dickinson and Company

11.8.1 Company Overview

11.9 Hologic, Inc.

11.9.1 Company Overview

11.10 OLYMPUS CORPORATION

11.10.1 Company Overview

11.11 Sysmex Corporation

11.11.1 Company Overview

11.12 Ortho-Clinical Diagnostics Inc.

11.12.1 Company Overview

11.13 DiaSorin S.p.A

11.13.1 Company Overview

11.14 Qiagen N.V.

11.14.1 Company Overview

11.15 Gen-Probe Incorporated

11.15.1 Company Overview

11.16 Phadia AB

11.16.1 Company Overview

11.17 Innogenetics NV

11.17.1 Company Overview

11.18 BioTech Tools

11.18.1 Company Overview

11.19 Immunosource

11.19.1 Company Overview

11.20 CorisBioConcept SPRL

11.20.1 Company Overview

11.21 MabCure Inc.

11.21.1 Company Overview

12.1 Clinical Chemisty Market Pipeline Products

12.2 Immuno Chemistry Market Pipeline Products

12.3 Haematology Market Pipeline Products

12.4 Infectious Immunology Market Pipeline Products

12.5 Microbiology Culture Market Pipeline Products

12.6 Histology and Cytology Market Pipeline Products

12.7 Genetic Testing Market Pipeline Products

13.1 Partnerships

13.1.1 QIAGEN Enters Into Distribution Agreement With Celera

13.1.2 QIAGEN Enters Into Licensing Agreement With Johns Hopkins University

13.1.3 DiaGenic Enters Into Distribution Agreement With Ferrer inCode

13.1.4 OraSure Technologies Enters Into An Agreement With Roche Diagnostics

13.1.5 Inverness Medical Innovations Enters Into Distribution Agreement With Epocal

13.1.6 Radient Pharmaceuticals Enters Into An Agreement With GenWay Biotech

14.1 Strategy and Business Planning

14.1.1 Jun 22, 2010: Ablynx Expands Into New R&D Facilities In Belgium

14.1.2 Dec 08, 2009: Genetix Expands Sales, Support And Service Organization In France And Benelux

14.2 Product News

14.2.1 May 27, 2010: Applied BioCode Receives CE Mark Certification For BioCode-1000 Analyzer

15.1 Definitions of Markets Covered in the Report

15.1.1 In Vitro Diagnostics

15.2 Research Methodology

15.3 Secondary Research

15.4 Primary Research

15.5 Models

15.6 Forecasts

15.7 Expert Panels

15.8 GlobalData Consulting

15.9 Currency Conversion

15.10 Contact Us

15.11 Disclaimer

Browse all Medical Devices Market Research Reports

Browse all GlobalData Market Research Reports

Browse all Newly Published Market Research Reports

Reports and Reports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.

Ms. Sunita

7557 Rambler road,

Suite 727, Dallas, TX 75231

Tel: +1-888-989-8004

Website: http://www.reportsandreports.com/

Blog: http://reportsnreports.wordpress.com/

Blog: http://reportsandreports.blogspot.com/

Dallas, TX: ReportsandReports announce it will carry Service Station Retailing Database 2010: Belgium Market Research Report in its Store.

Datamonitor’s Service Station Retailing Databases are essential for fuel retailing companies as well as suppliers to this sector. Available for over 25 countries across Europe, each one provides in-depth data on fuel sales, as well as forecourt shop, car wash and motorway network information for the sector as a whole and for each of the key players operating within it.

Original Source: Retail Market, Belgium Market

Browse all Retail Market Research Reports

Browse all Verdict Market Research Reports

Browse all Newly Published Market Research Reports

Reports and Reports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.

Ms. Sunita

7557 Rambler road,

Suite 727, Dallas, TX 75231

Tel: +1-888-989-8004

Website: http://www.reportsandreports.com/

Blog: http://reportsnreports.wordpress.com/

Blog: http://reportsandreports.blogspot.com/

Browse the complete Report on - Belgium Oil and Gas Report Q3 2010

Browse All Business Monitor International Market Research Reports

The new Belgium Oil & Gas Report from BMI forecasts that the country will account for 6.18% of developed European regional oil demand by 2014, while making no appreciable contribution to supply. In Developed Europe, overall oil consumption was an estimated 13.28mn barrels per day (b/d) in 2009. It is set to recover to around 13.44mn b/d by 2014. Developed Europe regional oil production was 6.96mn b/d in 2001, and in 2009 averaged an estimated 4.73mn b/d. It is set to fall to just 3.71mn b/d by 2014. Oil imports are growing steadily because supply is contracting and demand is rising, albeit slowly. In 2009, net crude imports were an estimated 9.18mn b/d. By 2014, they are expected to have reached 9.73mn b/d. Norway will remain the only major net exporter, with the UK a net importer.
As regards natural gas, the Developed Europe region in 2009 consumed an estimated 426bn cubic metres (bcm), with demand of 473bcm targeted for 2014, representing 9.6% growth. Production of an estimated 265bcm in 2009 is set to fall to 263bcm in 2014, which implies net imports rising from the estimated 2009 level of 161bcm to some 210bcm by the end of the period. Belgium’s share of gas consumption in 2009 was an estimated 3.99%, while it makes no contribution to production. By 2014, its share of gas consumption is forecast to be 3.78%.
We are sticking with our forecast that the OPEC basket of crudes will average US$83.00/bbl in 2010. Wide variations in crude differentials so far in 2010 make forecasting tricky for Brent, West Texas Intermediate (WTI) and Urals, but we believe the three benchmarks will average around US$85.11, US$88.22 and US$83.62/bbl respectively, with Dubai coming in at US$83.14. By 2011, there should be further growth in oil consumption and more room for OPEC to regain market share and reduce surplus capacity through higher production quotas. We are assuming a further increase in the OPEC basket price to an average US$85.00/bbl. For 2012 and beyond, we continue to use a central case forecast of US$90.00/bbl for the OPEC basket.
For 2010, the BMI assumption for premium unleaded gasoline is an average global price of US$96.83/bbl. The year-on-year (y-o-y) rise in 2010 gasoline prices is put at 38%. Gasoil in 2010 is expected to average US$92.45/bbl, with the full-year outturn representing a 37% increase from the 2009 level. For jet fuel in 2010, the annual level is forecast to be US$95.58/bbl. This compares with US$70.66/bbl in 2009. The 2010 average naphtha price is put by BMI at US$82.46/bbl, up 39% from the previous year’s level.
Belgian real GDP is assumed by BMI to have fallen by 3.1% in 2009, followed by forecast 1.1% growth in 2010. We are assuming average annual growth of 1.5% in 2010-2014. Oil demand is expected to have declined in 2009, before recovering slowly to reach 830,000b/d by 2013/14. From an estimated 17.0bcm in 2009, we expect to see gas demand rise to a minimum of 17.9bcm by 2014, all met by increased pipeline and liquefied natural gas (LNG) imports.
Between 2010 and 2019, we are forecasting an increase in Belgian oil and gas liquids consumption of 1.35%, with volumes rising slowly from an estimated 814,000b/d in 2010 to 825,000b/d by the end of the 10-year forecast period. Gas demand should rise from the estimated 2010 level of 17.2bcm to 18.8bcm by 2019, all based on LNG and pipeline imports. Details of BMI’s 10-year forecasts can be found in the appendix to this report.
According to BMI’s Country Risk team, Belgium’s long-term political risk score is 74.7, compared with the Developed Markets average of 86.7 and the global average of 63.7. Our long-term economic rating for the country is 66.5, below the Developed Markets average of 67.0 and above the global average of 53.7. Belgium has a privatised energy sector operating under EU guidelines. There is no upstream oil and gas segment but downstream oil and gas features a mixture of international oil companies (IOCs) and former state companies now in foreign hands. Both the gas and power markets are open to competition.

About Us

ReportsandReports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.


Contact:

Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
http://reportsandreports.blogspot.com/
http://reportsandreports.proarticles.co.uk/
http://reportsnreports.wordpress.com/

Original Source : –Oil and Gas Market
Buy Now : Market Research Report

Browse the complete Report on: Belgium Freight Transport Report Q4 2010

Browse All Business Monitor International Market Research Reports

In June 2010, Shanghai International Port (Group) (SIPG) acquired a EUR27.16mn (US$33.2mn) 25% stake in Belgium's Zeebrugge container port that is wholly owned by APM Terminals, a subsidiary of AP Moller Maersk. The purchase follows comments from SIPG chair Lu Haihu that the company will not seek further short-term opportunities for container terminal expansions at the Port of Shanghai. Lu told Seatrade Asia: 'Overall, Shanghai is suffering from an oversupply of box facilities, so we will not be launching any new facilities for the time being.' Zeebrugge, Belgium's second largest container port with a capacity of more than 2mn 20-foot equivalent units (TEUs), is an important gateway for trade and has remained relatively resilient to the difficult global macroeconomic environment, recording positive throughput growth in 2008 and 2009.
The collapse of the five-party coalition government in April 2010 started a new period of potential instability in Belgium, with complex negotiations taking place across the linguistic and ideological dividing lines of Belgian society. At the time of writing, the government has remained in office on a caretaker basis as talks continue. The danger was that during this time economic policy would drift and attention could be distracted from dealing with pressing fiscal problems. The country's deficit is calculated at around 6% of GDP and unemployment is also high at over 8%. BMI forecasts a slow recovery from 2009's recession, when the economy contracted by 3.1%. Our macroeconomic forecasts remain unchanged from our previous quarterly report but the downside risks have edged up. We expect GDP growth of 1.1% in 2010, accelerating gradually to 1.3% in 2011. Across our five-year forecast period to 2014 we expect average annual GDP growth of 1.5%.
We estimate Belgian airfreight volume fell very sharply in 2009, down by 21.9%. In 2010, we continue to project a very weak recovery of just 1.6%. The road freight story is similar. In 2009, the amount of cargo hauled by road contracted by 18.3%. For this year we predict growth of only 0.2% in road freight volumes. We also expect a modest recovery in railfreight in 2010 after a sharp fall in 2009. Volume was down by 14.6% last year and we forecast it to rise by only 0.6% in 2010.
At Belgium's major ports the picture is L-shaped, with a very big drop in cargo handling last year and a modest recovery in 2010. At the country's largest port, Antwerp, we expect volumes to go up by 0.4% this year, after a 16.7% fall in 2009. Container volumes will fare only marginally better. Belgium's foreign trade has not been volatile in recent years, rather the pattern has been for very slow growth in real terms. Total trade grew by 0.4% in 2009 and we forecast it expanding by the same amount in 2010. In fact, for the next five years imports and exports are projected to grow by an average rate of 0.4% per annum.
There are downside risks to our freight transport forecasts for Belgium. The most significant of these is that the negotiations to form a new coalition government drag on for a few more months, postponing urgent fiscal and economic policy decisions. This would almost certainly lower the country's growth prospects, with consequential knock-on effects for freight demand.

About Us

ReportsandReports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.


Contact:

Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
http://reportsandreports.blogspot.com/
http://reportsandreports.proarticles.co.uk/
http://reportsnreports.wordpress.com/

Browse the complete Report on: Belgium Pharmaceuticals and Healthcare Report Q4 2010

Browse All Business Monitor International Market Research Reports

Out of a maximum of 100, Belgium scored 65.1 in BMI’s Q410 Pharmaceuticals & Healthcare Business Environment Ratings (BERs), placing it joint fifth in the Western Europe matrix, on a par with the UK and below Germany, Switzerland, France and Sweden. Although growth in medicine sales is low, the country has a very large market in absolute terms. Furthermore, per-capita spending is high, there is a sizeable pensionable population and regulations are transparent. Emphasising its attractiveness as a pharmaceutical market globally, Belgium is placed joint 11th of the 77 markets surveyed by BMI’s everexpanding pharmaceutical universe.
As of April 2010, pharmacists in Belgium receive a fixed reimbursement amount of EUR3.88 plus VAT for every pack of medicines sold. This new system replaces the old proportional reimbursement rate of 31%, with an absolute limit of EUR7.44. Despite the new model taking away revenue-earning opportunities from the sale of high-value patented medicines, BMI believes the fixed reimbursement rate will provide significant revenues from the sale of lower-value generic medicines. BMI believes the additional reimbursement fees are one way in which the government is encouraging the consumption of lower-value generic medicines – generic substitution by pharmacists is permitted in Belgium. BMI notes that Belgium is behind markets such as Germany in terms of generic penetration and is among the lowest in Europe by volume and value. Medical traditions and the generic market share in Belgium more closely resemble those of France, with both markets characterised by a strong preference for branded prescription drugs. However, BMI believes the patent cliff and the consequent availability of low-value generic medicines will work towards pushing drug sales in the sector.
Despite a compound annual growth rate (CAGR) of 3.38% in local currency terms and 5.86% in US dollar terms from 2004-2009, BMI’s outlook for the Belgian drug market is less optimistic over the subsequent five years. From 2009-2014, a CAGR of 0.56% is projected in local currency terms (-1.69% in US dollar terms), largely as a result of the impending patent cliff and the consequent consumption of lower-value generic drugs in place of the high-value patented drugs, in addition to increasing government efforts to promote the consumption of generic medicines. By 2014, pharmaceutical expenditure in Belgium is expected to reach a value of EUR4.72bn (US$5.90bn), up from the calculated EUR4.59bn (US$6.43bn) in 2009.
Over a longer 10-year period, the growing use of high-value biologics, in particular personalised medicines, will spur a return to growth in Belgium, with a CAGR of 1.25% in local currency terms and 0.11% in US dollar terms through to 2019. As a result, BMI calculates that drug sales in Belgium will reach a value of EUR5.20bn (US$6.50bn) by 2019.

About Us

ReportsandReports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.


Contact:

Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
http://reportsandreports.blogspot.com/

http://reportsandreports.proarticles.co.uk/

http://reportsnreports.wordpress.com/